Our Research and Development
PRAECIS has a dedicated research and
development organization focused on the discovery and development of novel compounds with the potential to
address unmet medical needs or improve
One of our programs has moved beyond
the research phase and into clinical testing:
In addition, we have research
programs focused on developing therapies to treat certain autoimmune diseases, certain types of cancer
and other diseases.
The information about our product candidates includes assumptions about their effectiveness. These assumptions are based on theoretical scientific observations gleaned during various phases of pre-clinical and clinical development. With the exception of Plenaxis®, none of the drugs being developed by PRAECIS have received FDA (or other regulatory agency) approval for any of the potential indications discussed within this site.